))
The Big Story is back with a second season! The news culture of our times is noisy, crowded, and honestly so confusing. This is why we are coming every fortnight on your podcast platforms to help you make sense of the new and now. With two new hosts, Anjali and Prateek, the second season of The Big Story will feature longer and well-rounded discussions with experts across science, culture, technology, politics, and more. Tune in on your preferred podcast platform!
How Genentech is Innovating to Improve Diversity and Inclusion in Clinical Trials
Manage episode 294971568 series 2408553
By Greg Kefer, CMO, Lifelink Systems and Lifelink Systems. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.
The race to develop a COVID-19 vaccine shined a light on an issue that has challenged the pharmaceutical industry for years. Underrepresented minority communities are often disproportionately impacted by diseases, yet those groups are usually underrepresented in the clinical trials that are designed to assess the effectiveness of drugs that they need. As one of the world’s largest biotechnology companies, Genentech is tapping advanced mobile technology to help increase the diversity of trial participants and improve the experience.
In this episode of Digital Conversations, Nik Kolatkar, VP of Evidence Generation, US Medical Affairs at Genentech, joined Greg Kefer for a discussion about clinical trial innovation. Genentech runs a portfolio of 500 trials around the world and is using advanced technology to drive trust, education, and convenience for participants. Through smart, language-based interactions, digital navigators eliminate the need for participants to report to ivory tower academic centers and instead, provide the capabilities for anyone to be part of bringing advanced science to their communities, regardless of location, race, gender, income, or age.
67 episodes
